DOLOREX® (butorphanol tartrate injection)
Equine Pharmaceuticals
Product Description
DOLOREX® (butorphanol tartrate) is indicated for the relief of pain associated with colic in adult horses and yearlings. Clinical studies in the horse have shown that butorphanol tartrate alleviates abdominal pain associated with torsion, impaction, intussusception, spasmodic and tympanic colic, and postpartum pain.
WARNING: FOR USE IN HORSES ONLY. NOT FOR USE IN HORSES INTENDED FOR FOOD.
CAUTION: DOLOREX, a potent analgesic, should be used with caution with other sedative or analgesic drugs as these are likely to produce additive effects. There are no well controlled studies using butorphanol in breeding horses, weanlings, and foals. Therefore the drug should not be used in these groups.
ADVERSE REACTIONS: In clinical trials in horses, the most commonly observed side effect was slight ataxia which lasted 3 to 10 minutes. Marked ataxia was reported in 1.5% of the 327 horses treated. Mild sedation was reported in 9% of the horses.
| Product Name | Pkg Size | GTIN#/UPC# | UIN# |
|---|---|---|---|
| DOLOREX® | 1 x 50ml | 021784722506 | 017070 |
Images
Important Safety Information
DOLOREX® (butorphanol tartrate injection): FOR USE IN HORSES ONLY. DO NOT USE IN BREEDING HORSES, WEANLINGS, FOALS, AND IN HORSES INTENDED FOR HUMAN CONSUMPTION. DOLOREX is a potent analgesic that should be used with caution with other sedative or analgesic drugs as these are likely to produce additive effects.The most commonly observed side effect was slight ataxia lasting from 3 to 10 minutes. 1.5% of horses underwent marked ataxia and 9% had mild sedation with the use of this drug. For complete safety information please read label.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global